Vitamin K modulates cardiac action potential by blocking sodium and potassium ion channels

B Drolet1, A Emond, V Fortin

  • 1Institut de cardiologie de Québec, Hôpital Laval et Université Laval, Sainte-Foy, Québec, Canada.

Abstract

Insights

Intravenous vitamin K can alter heart electrical activity by affecting sodium and potassium currents. This study shows vitamin K impacts cardiac action potentials, potentially explaining adverse cardiovascular events.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Pharmacology

Background:

  • Rapid intravenous vitamin K administration has been linked to cardiovascular events like collapse and sudden death.
  • Understanding vitamin K's cardiac effects is crucial for patient safety.

Purpose of the Study:

  • To investigate the impact of vitamin K on cardiac action potentials.
  • To assess vitamin K's effects on key sodium (I(Na)) and potassium currents (I(Kr), I(Ks)).

Main Methods:

  • Guinea pig hearts were exposed to varying concentrations of vitamin K.
  • Monophasic action potential duration (MAPD(90)) was measured.
  • Patch-clamp electrophysiology was used to study ionic currents in ventricular myocytes.

Main Results:

  • Vitamin K increased action potential duration at 2.3 micromol/L and caused inexcitability at higher concentrations.
  • Vitamin K significantly reduced sodium current (I(Na)) by approximately 50% at 10 micromol/L.
  • It concentration-dependently blocked rapid potassium current (I(Kr)) with an IC(50) of 2.3 micromol/L, while I(Ks) was less affected.

Conclusions:

  • Therapeutic concentrations of intravenous vitamin K modulate cardiac action potentials.
  • Vitamin K blocks ionic currents critical for cardiac depolarization and repolarization.
  • These electrophysiological effects may underlie observed cardiovascular adverse events.

Related Concept Videos

Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...